575 related articles for article (PubMed ID: 23709595)
1. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.
Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium.
DeNicola M; Du J; Wang Z; Yano N; Zhang L; Wang Y; Qin G; Zhuang S; Zhao TC
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E630-43. PubMed ID: 25117407
[TBL] [Abstract][Full Text] [Related]
3. Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine.
Chen WJY; Diamant M; de Boer K; Harms HJ; Robbers LFHJ; van Rossum AC; Kramer MHH; Lammertsma AA; Knaapen P
Cardiovasc Diabetol; 2017 May; 16(1):67. PubMed ID: 28526033
[TBL] [Abstract][Full Text] [Related]
4. Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus.
Rosa CM; Gimenes R; Campos DH; Guirado GN; Gimenes C; Fernandes AA; Cicogna AC; Queiroz RM; Falcão-Pires I; Miranda-Silva D; Rodrigues P; Laurindo FR; Fernandes DC; Correa CR; Okoshi MP; Okoshi K
Cardiovasc Diabetol; 2016 Sep; 15(1):126. PubMed ID: 27585437
[TBL] [Abstract][Full Text] [Related]
5. Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits.
Zhang X; Zhang Z; Yang Y; Suo Y; Liu R; Qiu J; Zhao Y; Jiang N; Liu C; Tse G; Li G; Liu T
Cardiovasc Diabetol; 2018 Dec; 17(1):160. PubMed ID: 30591063
[TBL] [Abstract][Full Text] [Related]
6. A novel oral glucagon-like peptide 1 receptor agonist protects against diabetic cardiomyopathy via alleviating cardiac lipotoxicity induced mitochondria dysfunction.
Qian P; Tian H; Wang Y; Lu W; Li Y; Ma T; Gao X; Yao W
Biochem Pharmacol; 2020 Dec; 182():114209. PubMed ID: 32860826
[TBL] [Abstract][Full Text] [Related]
7. Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor.
Tatarkiewicz K; Sablan EJ; Polizzi CJ; Villescaz C; Parkes DG
Am J Physiol Regul Integr Comp Physiol; 2014 Apr; 306(7):R490-8. PubMed ID: 24477544
[TBL] [Abstract][Full Text] [Related]
8. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y
Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911
[TBL] [Abstract][Full Text] [Related]
9. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart.
Li C; Zhang J; Xue M; Li X; Han F; Liu X; Xu L; Lu Y; Cheng Y; Li T; Yu X; Sun B; Chen L
Cardiovasc Diabetol; 2019 Feb; 18(1):15. PubMed ID: 30710997
[TBL] [Abstract][Full Text] [Related]
10. Effects of Sodium-Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice.
Croteau D; Luptak I; Chambers JM; Hobai I; Panagia M; Pimentel DR; Siwik DA; Qin F; Colucci WS
J Am Heart Assoc; 2021 Jul; 10(13):e019995. PubMed ID: 34169737
[TBL] [Abstract][Full Text] [Related]
11. Expression of CTRP3, a novel adipokine, in rats at different pathogenic stages of type 2 diabetes mellitus and the impacts of GLP-1 receptor agonist on it.
Li X; Jiang L; Yang M; Wu YW; Sun SX; Sun JZ
J Diabetes Res; 2014; 2014():398518. PubMed ID: 25177707
[TBL] [Abstract][Full Text] [Related]
12. Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus.
Gimenes R; Gimenes C; Rosa CM; Xavier NP; Campos DHS; Fernandes AAH; Cezar MDM; Guirado GN; Pagan LU; Chaer ID; Fernandes DC; Laurindo FR; Cicogna AC; Okoshi MP; Okoshi K
Cardiovasc Diabetol; 2018 Jan; 17(1):15. PubMed ID: 29343259
[TBL] [Abstract][Full Text] [Related]
13. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes.
Kodera R; Shikata K; Kataoka HU; Takatsuka T; Miyamoto S; Sasaki M; Kajitani N; Nishishita S; Sarai K; Hirota D; Sato C; Ogawa D; Makino H
Diabetologia; 2011 Apr; 54(4):965-78. PubMed ID: 21253697
[TBL] [Abstract][Full Text] [Related]
15. Exenatide improves liver mitochondrial dysfunction and insulin resistance by reducing oxidative stress in high fat diet-induced obese mice.
Wang Z; Hou L; Huang L; Guo J; Zhou X
Biochem Biophys Res Commun; 2017 Apr; 486(1):116-123. PubMed ID: 28274877
[TBL] [Abstract][Full Text] [Related]
16. Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone.
Henderson BC; Sen U; Reynolds C; Moshal KS; Ovechkin A; Tyagi N; Kartha GK; Rodriguez WE; Tyagi SC
Int J Biol Sci; 2007 Sep; 3(6):385-92. PubMed ID: 17848984
[TBL] [Abstract][Full Text] [Related]
17. A novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure.
Bradley JM; Li Z; Organ CL; Polhemus DJ; Otsuka H; Islam KN; Bhushan S; Gorodnya OM; Ruchko MV; Gillespie MN; Wilson GL; Lefer DJ
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H311-H321. PubMed ID: 29101177
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes.
Ye Y; Qian J; Castillo AC; Ling S; Ye H; Perez-Polo JR; Bajaj M; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2013 Jan; 304(1):H131-41. PubMed ID: 23103492
[TBL] [Abstract][Full Text] [Related]
19. FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress.
Lin C; Guo Y; Xia Y; Li C; Xu X; Qi T; Zhang F; Fan M; Hu G; Zhao H; Zhao H; Liu R; Gao E; Yan W; Tao L
J Mol Cell Cardiol; 2021 Nov; 160():27-41. PubMed ID: 34224725
[TBL] [Abstract][Full Text] [Related]
20. Exendin-4 improves cardiac function in mice overexpressing monocyte chemoattractant protein-1 in cardiomyocytes.
Younce CW; Niu J; Ayala J; Burmeister MA; Smith LH; Kolattukudy P; Ayala JE
J Mol Cell Cardiol; 2014 Nov; 76():172-6. PubMed ID: 25200599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]